Greetings #RheumJC friends!
First, we have an exciting announcement: We’ve teamed up with Healio Rheumatology, who is going to be helping the #RheumJC team with summaries of articles, graphics, and helping to expand the reach of our journal club. We’re greatly looking forward to working with them!
Our next journal club will be Thursday, February 27th at 9pm Eastern Time / 8pm Central Time (click here to find this in your local time zone).
We’re going to be discussing the two articles reporting results from the TULIP–1 and TULIP–2 trials, which looked at the use of the type I interferon receptor blocker anifrolumab in systemic lupus erythematosis.
- Please remember to try to stay on topic whenever possible.
- Be polite and courteous.
- Do not violate HIPAA.